PA Medical News about Campylobacter jejuni

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Antimicrobial Activity of Two Propolis Samples Against Human Campylobacter jejuni
Journal of Medicinal Food, 11/03/09

Campana R et al. – The minimal inhibitory concentrations (MICs) of EEPs and flavonoids for C. jejuni isolates were determined by the agar dilution method. EEPs showed MIC values of 0.3125–0.156mg/mL for all C. jejuni strains; galangin and quercetin gave MICs ranging from 0.250 to 0.125mg/mL. Thus propolis preparations could be used as support to traditional therapy for Campylobacter infection, especially when the antibiotic agents show no activity against this microorganism.

Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohns disease
Inflammatory Bowel Disease, 11/05/09 Relevance Score: 68%

Comparison of basal broth media for the optimal laboratory recovery of Campylobacter jejuni and Campylobacter coli
Irish Journal of Medical Science, 11/09/09 Relevance Score: 67%

Outer membrane vesicle-mediated release of cytolethal distending toxin from Campylobacter jejuni
BMC Microbiology, 10/21/09 Relevance Score: 67%

AI-2 does not Function as a Quorum Sensing Molecule in Campylobacter jejuni during exponential growth in vitro
BMC Microbiology, 10/12/09 Relevance Score: 67%

Campylobacter jejuni abscess, encephalomyelitis, and acute polyradiculoneuropathy
Muscle & Nerve, 10/07/09 Relevance Score: 67%